Mark For: TUZON™ trademark registration is intended to cover the categories of scientific research and development services; Research and development of tests for pathogenic diseases; Pathogenic disease testing and communicating those results; Biomedical and biopharmaceutical research and development; Scientific and medical research in the fields of immunology, virology, molecular biology, RNA biology, cancer, cellular biology, molecular genetics, microbiology, genomics, gene editing and genome engineering; Consulting services in the fields of immunology, virology, molecular biology, RNA biology, cancer, cellular biology, molecular genetics, microbiology, genomics, gene editing and genome engineering; Scientific research in the field of antibodies for use in testing, vaccine design, therapeutic agents; Consulting services in the field of antibodies for use in testing, vaccine design, therapeutic agents; Scientific research in the field of bioinformatics, sequencing, epidemiology, public health; Developing DNA-, RNA-, protein-based reagents and other biological reagents in support of scientific research; Providing protocols, reagents, and other scientific information and tools in support of scientific and medical research; Developing and providing information about molecular biology research tools, specifically vectors, plasmids, nucleic acid fragments, biological libraries and entities. [all]
Status
2020-08-01 UTC
LIVE APPLICATION Awaiting Examination
The trademark application has been accepted by the Office (has met the minimum filing requirements) and has not yet been assigned to an examiner.
(Computer, scientific & legal) Scientific and technological services and research and design relating thereto: industrial analysis and research services; design and development of computer hardware and software; legal services.
Filed Use
No
Current Use
No
Intent To Use
Yes
Filed ITU
Yes
44D Filed
No
44E Current
No
66A Current
No
Current Basis
No
No Basis
No
Timeline
2020-07-28
Application Filed
2020-07-31
Location: NEW APPLICATION PROCESSING
2020-07-31
Status: Live/Pending
2020-07-31
Status: New application will be assigned to an examining attorney approximately 3 months after filing date.
IC 042. US 100 101. G & S: Scientific research and development services; Research and development of tests for pathogenic diseases; Pathogenic disease testing and communicating those results; Biomedical and biopharmaceutical research and development; Scientific and medical research in the fields of immunology, virology, molecular biology, RNA biology, cancer, cellular biology, molecular genetics, microbiology, genomics, gene editing and genome engineering; Consulting services in the fields of immunology, virology, molecular biology, RNA biology, cancer, cellular biology, molecular genetics, microbiology, genomics, gene editing and genome engineering; Scientific research in the field of antibodies for use in testing, vaccine design, therapeutic agents; Consulting services in the field of antibodies for use in testing, vaccine design, therapeutic agents; Scientific research in the field of bioinformatics, sequencing, epidemiology, public health; Developing DNA-, RNA-, protein-based reagents and other biological reagents in support of scientific research; Providing protocols, reagents, and other scientific information and tools in support of scientific and medical research; Developing and providing information about molecular biology research tools, specifically vectors, plasmids, nucleic acid fragments, biological libraries and entities
International Codes:
42
U.S. Codes:
100,101
Type Code
Type
GS0421
Scientific research and development services; Research and development of tests for pathogenic diseases; Pathogenic disease testing and communicating those results; Biomedical and biopharmaceutical research and development; Scientific and medical research in the fields of immunology, virology, molecular biology, RNA biology, cancer, cellular biology, molecular genetics, microbiology, genomics, gene editing and genome engineering; Consulting services in the fields of immunology, virology, molecular biology, RNA biology, cancer, cellular biology, molecular genetics, microbiology, genomics, gene editing and genome engineering; Scientific research in the field of antibodies for use in testing, vaccine design, therapeutic agents; Consulting services in the field of antibodies for use in testing, vaccine design, therapeutic agents; Scientific research in the field of bioinformatics, sequencing, epidemiology, public health; Developing DNA-, RNA-, protein-based reagents and other biological reagents in support of scientific research; Providing protocols, reagents, and other scientific information and tools in support of scientific and medical research; Developing and providing information about molecular biology research tools, specifically vectors, plasmids, nucleic acid fragments, biological libraries and entities
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.